Six companies in five states have received warning letters from government agencies for selling illegal products containing delta-8 THC made from industrial hemp. The U.S. Food & Drug Administration (FDA) […]
FDA, FTC issue new round of warnings over hemp-derived synthetic THC Read More »
The U.S. Food & Drug Administration (FDA) has issued a new round of warnings to U.S. CBD vendors, citing violations of the Food, Drug & Cosmetic Act. FDA said the
FDA issues new round of warnings to vendors of CBD, delta-8 Read More »
The U.S. Food and Drug Administration (FDA) today warned five companies over what it calls the illegal sale of products containing delta-8 THC. Companies receiving warning letters were ATLRx Inc.,
Five companies targeted in first FDA warnings over delta-8 THC products Read More »
After years of delay, frustration, and regulatory ambiguity, the U.S. House Oversight Committee is hold a hearing this week that stakeholders hope will mark a turning point for the embattled
Delayed FDA action on CBD faces scrutiny as House hearing revives regulatory hopes Read More »
Six marketers of products containing delta-8 THC have received warnings from the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) over snacks the agencies say appeal to
FDA, FTC warn six companies over ‘copycat’ marketing of delta-8 products to kids Read More »
With prospects slim for CBD to be regulated in the absence of an updated U.S. Farm Bill, the U.S. Food and Drug Administration (FDA) appears it will continue past practice
FDA signals it will keep up enforcement vs. CBD, delta-8 in absence of Farm Bill Read More »
Federal CBD policy should advance research that can inform consumers about risk while at the same time giving stakeholders regulatory certainty, a senior advisor at the U.S. Food and Drug
‘Large, innovative’ CBD sector needs balanced rules, says FDA advisor Read More »
The U.S. Food and Drug Administration (FDA) says it is only months away from finalizing recommendations for how cannabis should best be regulated and whether additional legislation from Congress is
FDA recommendations on cannabis could signal progress for CBD Read More »
The Oversight Committee of the U.S. House of Representatives says it will investigate the U.S. Food and Drug Administration (FDA) over its regulatory jurisdiction of hemp-derived CBD. The committee is
U.S. house committee to investigate FDA over CBD rulemaking Read More »
CBD stakeholders say they hope the appointment of a cannabis policy expert at the U.S. Food & Drug Administration (FDA) signals the agency may finally begin to establish a regulatory
U.S. CBD stakeholders cheer appointment of cannabis expert at FDA Read More »
